⌘K

Login Start Free

Home/Filings/4/0001062993-23-018393

4//SEC Filing

SCARLETT JOHN A 4

Accession 0001062993-23-018393

CIK 0000886744other

View on SEC.gov Company Profile

Filed

Sep 20, 8:00 PM ET

Accepted

Sep 21, 8:32 PM ET

Size

5.4 KB

Accession

0001062993-23-018393

Insider Transaction Report

Form 4

Period: 2023-08-15

SCARLETT JOHN A

DirectorChief Executive Officer

Transactions

Award
Employee Stock Option (Right to buy)
2023-08-15+500,000→ 500,000 total
Exercise: $1.72From: 2023-08-15Exp: 2028-11-06→ Common Stock (500,000 underlying)

Footnotes (1)

[F1]Performance-based stock option granted on November 7, 2018 and vested in full on August 15, 2023 upon acceptance of the NDA by the US FDA for imetelstat in lower risk MDS.

Documents

1 file

4
form4.xmlPrimary
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Issuer

GERON CORP

CIK 0000886744

Entity typeother

Related Parties

1

filerCIK 0001270928

Filing Metadata

Form type: 4
Filed: Sep 20, 8:00 PM ET
Accepted: Sep 21, 8:32 PM ET
Size: 5.4 KB

View on SEC.gov